Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Methylprednisolone pulse therapy works best for recent and specific types of severe alopecia areata.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

Early onset, severe types, nail changes, family history, and body hair loss worsen alopecia areata prognosis; sticking to treatment helps.

Minoxidil works better for hair regrowth if you have higher SULT1A1 enzyme activity and ATP concentration.

Certain scalp tissue features can predict how well alopecia areata responds to steroid injections.

Age is more important than BMI for IVF success in women with infertility and PCOS.

Younger people and those with existing acne are more likely to get folliculitis after hair restoration surgery, but it doesn't affect the overall good hair growth result.

Early-onset alopecia, especially with a family history, leads to worse outcomes and more related health issues.

Alopecia areata is unpredictable, with limited treatment effectiveness, especially in severe cases.

Frontal fibrosing alopecia has a higher remission rate than lichen planopilaris.

Type 3 acromegaly patients have more health issues and higher death risk.

Melanoma survival rates vary by state and are better where incomes are higher, more people have health insurance and education, and there are more dermatologists.

Some treatments for folliculitis decalvans work well, with tetracyclines and a mix of rifampicin and clindamycin being most effective.

Rash from EGFRI treatment can indicate both side effects and treatment effectiveness.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

Higher IL-17A levels indicate more severe alopecia areata.

Ophiasis mainly affects females, lasts longer, and has lower regrowth rates, with a new classification system helping predict treatment response.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Too much epidermal growth factor can cause hair loss.

High levels of NEDD4-TV3 and IGF-1 may predict and contribute to keloid formation.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

Guidelines help design better trials to compare alopecia areata treatments.

Children and adults with Cushing's disease show different symptoms and males have more severe cases; surgery outcomes can be predicted by certain factors.

Juvenile alopecia areata is more severe and has a worse prognosis than maturity-onset alopecia areata.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Early-onset alopecia areata doesn't consistently predict poor long-term outcomes.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Complete COVID-19 vaccination reduces the risk of long COVID.